Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience

Background: We analysed a series of malignant pleural mesothelioma (MPM) patients who consecutively underwent extended Pleurectomy/Decortication (eP/D) in a centre with a high level of thoracic surgery experience (IRCCS Humanitas Research Hospital) to explore postoperative morbidity and mortality, p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giuseppe Mangiameli, Edoardo Bottoni, Emanuele Voulaz, Umberto Cariboni, Alberto Testori, Alessandro Crepaldi, Veronica Maria Giudici, Emanuela Morenghi, Marco Alloisio
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/38fb7eae435f466ba99b3a0d1df1bfc7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:38fb7eae435f466ba99b3a0d1df1bfc7
record_format dspace
spelling oai:doaj.org-article:38fb7eae435f466ba99b3a0d1df1bfc72021-11-11T17:36:04ZExtended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience10.3390/jcm102149682077-0383https://doaj.org/article/38fb7eae435f466ba99b3a0d1df1bfc72021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/4968https://doaj.org/toc/2077-0383Background: We analysed a series of malignant pleural mesothelioma (MPM) patients who consecutively underwent extended Pleurectomy/Decortication (eP/D) in a centre with a high level of thoracic surgery experience (IRCCS Humanitas Research Hospital) to explore postoperative morbidity and mortality, pattern of recurrence and survival. Methods: A retrospective analysis was performed on MPM patients underwent eP/D in our centre from 2010 to 2021. All patients were identified from our departmental database. Postoperative complications were scored according to Clavien–Dindo criteria. Survival analysis was performed by the Kaplan–Meier methods and Cox multivariable analysis. Results: Eighty-five patients underwent extended pleurectomy decortication (eP/D) during study period. Macroscopical residual disease (R2) was reported in one case. A neoadjuvant chemotherapy regiment was administrated in 88% of the surgical cohort. A complete trimodality treatment including induction with platinum agents and pemetrexed, radical cytoreductive surgery and volumetric modulated arc therapy technology (VMAT) could be administered in 63 patients (74%). Postoperative morbidity rate was 54.11%, major complications (defined as Clavien–Dindo ≥ 3) were reported in 11 patients (12.9%). Thirty-day mortality and 90-day mortality were, respectively, 2.35% and 3.53%. Median disease-free and overall survival were, respectively, 13.7 and 25.5 months. The occurrence of major complications (Clavien–Dindo ≥ 3), operative time, pT3–T4, pathological node involvement (pN+) were prognostic factors associated with worse survival. Conclusions: In our experience, eP/D is a well-tolerated procedure with acceptable mortality and morbidity, allowing for the administration of trimodality regimens in most patients. eP/D offered in a multimodality treatment setting have satisfactory long term oncological results. To obtain best oncological results the goal of surgery should be macroscopic complete resection in carefully selected patients (clinical N0).Giuseppe MangiameliEdoardo BottoniEmanuele VoulazUmberto CariboniAlberto TestoriAlessandro CrepaldiVeronica Maria GiudiciEmanuela MorenghiMarco AlloisioMDPI AGarticlemalignant pleural mesotheliomaextended pleurectomy/decortication (eP/D)trimodality treatmentMedicineRENJournal of Clinical Medicine, Vol 10, Iss 4968, p 4968 (2021)
institution DOAJ
collection DOAJ
language EN
topic malignant pleural mesothelioma
extended pleurectomy/decortication (eP/D)
trimodality treatment
Medicine
R
spellingShingle malignant pleural mesothelioma
extended pleurectomy/decortication (eP/D)
trimodality treatment
Medicine
R
Giuseppe Mangiameli
Edoardo Bottoni
Emanuele Voulaz
Umberto Cariboni
Alberto Testori
Alessandro Crepaldi
Veronica Maria Giudici
Emanuela Morenghi
Marco Alloisio
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
description Background: We analysed a series of malignant pleural mesothelioma (MPM) patients who consecutively underwent extended Pleurectomy/Decortication (eP/D) in a centre with a high level of thoracic surgery experience (IRCCS Humanitas Research Hospital) to explore postoperative morbidity and mortality, pattern of recurrence and survival. Methods: A retrospective analysis was performed on MPM patients underwent eP/D in our centre from 2010 to 2021. All patients were identified from our departmental database. Postoperative complications were scored according to Clavien–Dindo criteria. Survival analysis was performed by the Kaplan–Meier methods and Cox multivariable analysis. Results: Eighty-five patients underwent extended pleurectomy decortication (eP/D) during study period. Macroscopical residual disease (R2) was reported in one case. A neoadjuvant chemotherapy regiment was administrated in 88% of the surgical cohort. A complete trimodality treatment including induction with platinum agents and pemetrexed, radical cytoreductive surgery and volumetric modulated arc therapy technology (VMAT) could be administered in 63 patients (74%). Postoperative morbidity rate was 54.11%, major complications (defined as Clavien–Dindo ≥ 3) were reported in 11 patients (12.9%). Thirty-day mortality and 90-day mortality were, respectively, 2.35% and 3.53%. Median disease-free and overall survival were, respectively, 13.7 and 25.5 months. The occurrence of major complications (Clavien–Dindo ≥ 3), operative time, pT3–T4, pathological node involvement (pN+) were prognostic factors associated with worse survival. Conclusions: In our experience, eP/D is a well-tolerated procedure with acceptable mortality and morbidity, allowing for the administration of trimodality regimens in most patients. eP/D offered in a multimodality treatment setting have satisfactory long term oncological results. To obtain best oncological results the goal of surgery should be macroscopic complete resection in carefully selected patients (clinical N0).
format article
author Giuseppe Mangiameli
Edoardo Bottoni
Emanuele Voulaz
Umberto Cariboni
Alberto Testori
Alessandro Crepaldi
Veronica Maria Giudici
Emanuela Morenghi
Marco Alloisio
author_facet Giuseppe Mangiameli
Edoardo Bottoni
Emanuele Voulaz
Umberto Cariboni
Alberto Testori
Alessandro Crepaldi
Veronica Maria Giudici
Emanuela Morenghi
Marco Alloisio
author_sort Giuseppe Mangiameli
title Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
title_short Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
title_full Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
title_fullStr Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
title_full_unstemmed Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
title_sort extended pleurectomy/decortication for malignant pleural mesothelioma: humanitas’s experience
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/38fb7eae435f466ba99b3a0d1df1bfc7
work_keys_str_mv AT giuseppemangiameli extendedpleurectomydecorticationformalignantpleuralmesotheliomahumanitassexperience
AT edoardobottoni extendedpleurectomydecorticationformalignantpleuralmesotheliomahumanitassexperience
AT emanuelevoulaz extendedpleurectomydecorticationformalignantpleuralmesotheliomahumanitassexperience
AT umbertocariboni extendedpleurectomydecorticationformalignantpleuralmesotheliomahumanitassexperience
AT albertotestori extendedpleurectomydecorticationformalignantpleuralmesotheliomahumanitassexperience
AT alessandrocrepaldi extendedpleurectomydecorticationformalignantpleuralmesotheliomahumanitassexperience
AT veronicamariagiudici extendedpleurectomydecorticationformalignantpleuralmesotheliomahumanitassexperience
AT emanuelamorenghi extendedpleurectomydecorticationformalignantpleuralmesotheliomahumanitassexperience
AT marcoalloisio extendedpleurectomydecorticationformalignantpleuralmesotheliomahumanitassexperience
_version_ 1718432056316264448